No spam - just the good stuff

Subscribe to our newsletter
Hidden
  • News
  • Investment
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
News > Longevity 2020Prescribing Longevity

Prescribing Longevity

Author: Phil Newman  |  Published on: May 1, 2020  |  Last updated: May 10, 2022

Oliver Zolman

Director, 20one Consulting Ltd

Prescribing Longevity


 

Share this article:

Editor's choice

Empowering cells to boost energy and recovery is a winning move

Study disproves benefits of probiotics for vaginal health

How do Tour De France athletes recover so fast? Performance coach reveals the secret

9 proven ways to beat brain fog and enhance your energy

Longevity investment platform opens-up to international investors

Urolithin A research opens door to osteoarthritis relief

Popular articles

Stay cool: the longevity tech that “shows insane promise”

Does SIRT6 hold the key to human longevity?

Tally up! Consumer longevity company lands $10m

Longevity: ‘money-spinning cult’ or the future of health?

Zuzalu: a pop-up city with longevity at its heart

Longevity AI partners with Israel’s leading HMO

More like this

Unlocking longevity potential: GlycanAge’s approach to longevity, healthspan and menopause

Diagnostics

A strong patent portfolio delivers a competitive edge in the longevity space

Investment

Juvenescence: Think aging up, rather than disease down

Features

Combilytics: Taking a combined approach to senescence

Supplements

Investing in Longevity 101

Economy

Getting comfortable with senotherapeutics

Biotech

New longevity conference will span research to evidence-based clinical practice

Videos

Stay cool: the longevity tech that “shows insane promise”

Features

‘This conference is going to be the best yet’

Economy

GlycanAge: A novel platform for guiding improvements to longevity and healthspan

Diagnostics

From the cradle to the grave – the long way round

Videos

Mitochondrial therapy could tackle aging from the inside out

Biotech

Fountain Life: longevity real estate built on prevention and detection

Investment

Why finding out your GlycanAge could put more time on the clock

Diagnostics

More power to you – why energy could be the key to longevity

Biotech

Cyclarity: When bad guy cells have a change of heart

Biotech

Find us here ...

Subscribe to our newsletter

Hidden

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.